Analyses of the short-and long-term graft survival after kidney transplantation in Europe between 1986 and 2015 M Coemans, C Süsal, B Döhler, D Anglicheau, M Giral, O Bestard, ... Kidney international 94 (5), 964-973, 2018 | 263 | 2018 |
Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome A Senev, M Coemans, E Lerut, V Van Sandt, L Daniëls, D Kuypers, ... American Journal of Transplantation 19 (3), 763-780, 2019 | 125 | 2019 |
Eplet mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, rejection, and graft failure after kidney transplantation: an observational cohort study A Senev, M Coemans, E Lerut, V Van Sandt, J Kerkhofs, L Daniëls, ... Journal of the American Society of Nephrology 31 (9), 2193-2204, 2020 | 119 | 2020 |
Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation A Senev, E Lerut, V Van Sandt, M Coemans, J Callemeyn, B Sprangers, ... American Journal of Transplantation 19 (11), 3100-3113, 2019 | 82 | 2019 |
Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: a multicentre, prospective study E Van Loon, S Gazut, S Yazdani, E Lerut, H de Loor, M Coemans, ... EBioMedicine 46, 463-472, 2019 | 69 | 2019 |
Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation A Senev, MP Emonds, V Van Sandt, E Lerut, M Coemans, B Sprangers, ... American Journal of Transplantation 20 (12), 3367-3378, 2020 | 59 | 2020 |
Missing self–induced microvascular rejection of kidney allografts: a population-based study J Callemeyn, A Senev, M Coemans, E Lerut, B Sprangers, D Kuypers, ... Journal of the American Society of Nephrology 32 (8), 2070-2082, 2021 | 45 | 2021 |
Assessing the complex causes of kidney allograft loss E Van Loon, A Senev, E Lerut, M Coemans, J Callemeyn, JM Van Keer, ... Transplantation 104 (12), 2557-2566, 2020 | 45 | 2020 |
Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation J Callemeyn, H Ameye, E Lerut, A Senev, M Coemans, E Van Loon, ... American Journal of Transplantation 21 (7), 2413-2423, 2021 | 44 | 2021 |
Bias by censoring for competing events in survival analysis M Coemans, G Verbeke, B Döhler, C Süsal, M Naesens bmj 378, 2022 | 28 | 2022 |
Occurrence of diabetic nephropathy after renal transplantation despite intensive glycemic control: an observational cohort study M Coemans, E Van Loon, E Lerut, P Gillard, B Sprangers, A Senev, ... Diabetes care 42 (4), 625-634, 2019 | 28 | 2019 |
Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies A Senev, E Van Loon, E Lerut, J Callemeyn, M Coemans, V Van Sandt, ... Kidney international 100 (2), 401-414, 2021 | 27 | 2021 |
Effect of donor nephrectomy time during circulatory-dead donor kidney retrieval on transplant graft failure L Heylen, J Pirenne, U Samuel, I Tieken, M Coemans, M Naesens, ... Journal of British Surgery 107 (1), 87-95, 2020 | 19 | 2020 |
Long-Term Survival after Kidney Transplantation. Y Fenig, S Suresh, C Rochon The New England journal of medicine 386 (5), 499-499, 2022 | 16 | 2022 |
Circulating donor-specific anti-HLA antibodies associate with immune activation independent of kidney transplant histopathological findings E Van Loon, B Lamarthée, T Barba, S Claes, M Coemans, H de Loor, ... Frontiers in immunology 13, 818569, 2022 | 15 | 2022 |
Association of HLA mismatches and histology suggestive of antibody-mediated injury in the absence of donor-specific anti-HLA antibodies A Senev, E Lerut, M Coemans, J Callemeyn, HC Copley, F Claas, ... Clinical Journal of the American Society of Nephrology 17 (8), 1204-1215, 2022 | 14 | 2022 |
The evolution of histological changes suggestive of antibody‐mediated injury, in the presence and absence of donor‐specific anti‐HLA antibodies M Coemans, A Senev, E Van Loon, E Lerut, B Sprangers, D Kuypers, ... Transplant International 34 (10), 1824-1836, 2021 | 11 | 2021 |
Apixaban in patients on haemodialysis: a single-dose pharmacokinetics study I Van den Bosch, T Bouillon, P Verhamme, T Vanassche, M Jacquemin, ... Nephrology Dialysis Transplantation 36 (5), 884-889, 2021 | 10 | 2021 |
Association of Predicted HLA T-Cell Epitope Targets and T-Cell–Mediated Rejection After Kidney Transplantation A Senev, E Van Loon, E Lerut, M Coemans, J Callemeyn, L Daniëls, ... American Journal of Kidney Diseases 80 (6), 718-729. e1, 2022 | 8 | 2022 |
Forecasting of patient-specific kidney transplant function with a sequence-to-sequence deep learning model E Van Loon, W Zhang, M Coemans, M De Vos, MP Emonds, I Scheffner, ... JAMA network open 4 (12), e2141617-e2141617, 2021 | 8 | 2021 |